SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-157077
Filing Date
2009-07-28
Accepted
2009-07-28 17:26:17
Documents
9
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 540529
2 SUNESIS PHARMACEUTICALS, INC. CHANGE OF CONTROL PAYMENT PLAN dex1062.htm EX-10.62 91456
3 SUNESIS PHARMACEUTICALS, INC. 2009 BONUS PROGRAM dex1063.htm EX-10.63 16660
4 MEDICAL BENEFITS ARRANGEMENT WITH JAMES W. YOUNG, PH.D. dex1065.htm EX-10.65 974
5 CERTIFICATION OF CEO AS REQUIRED BY RULE 13A-14(A) dex311.htm EX-31.1 9643
6 CERTIFICATION OF CFO AS REQUIRED BY RULE 13A-14(A) dex312.htm EX-31.2 9846
7 CERTIFICATION OF CEO AS REQUIRED BY RULE 13A-14(B) dex321.htm EX-32.1 3860
8 CERTIFICATION OF CFO AS REQUIRED BY RULE 13A-14(B) dex322.htm EX-32.2 4099
9 GRAPHIC g79112g96r69.jpg GRAPHIC 10168
  Complete submission text file 0001193125-09-157077.txt   692797
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 09968074
SIC: 2834 Pharmaceutical Preparations